Clinical trial

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT05355701

StatusACTIVE_NOT_RECRUITING
Study typeINTERVENTIONAL
Start date2022-07-05
PhasePHASE1

Study timeline

Study start (actual)2022-07-05Date precision: day
Registry last updated2026-09-01
Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Sponsors & collaborators

Pfizerlead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.